Ketoprofen-Solofarm, 50 mg/ml 2 ml 10 pcs.

Symptomatic therapy of pain syndrome, including inflammatory processes of different origin: rheumatoid arthritis; seronegative arthritis: ankylosing spondylitis (Behterev’s disease), psoriatic arthritis, reactive arthritis (Reiter’s syndrome); gout, pseudopodagra; degenerative diseases of the musculoskeletal system, including arthritis.including osteoarthritis; mild, moderate and expressed pain syndrome in headache, migraine, tendonitis, bursitis, myalgia, neuralgia, radiculitis; post-traumatic and postoperative pain syndrome, including those accompanied with inflammation and fever; pain syndrome in cancer; algodysmenorrhea.

Indications

Symptomatic treatment of pain syndrome, incl. in inflammatory processes of various origins: rheumatoid arthritis; seronegative arthritis: ankylosing spondylitis (Bechterew’s disease), psoriatic arthritis, reactive arthritis (Reiter’s syndrome); gout, pseudogout; degenerative diseases of the musculoskeletal system, incl. osteoarthritis; mild, moderate and severe pain syndrome with headaches, migraines, tendinitis, bursitis, myalgia, neuralgia, radiculitis; post-traumatic and postoperative pain syndrome, incl. accompanied by inflammation and fever; pain syndrome in cancer; algodismenorrhea.

Special instructions

With long-term use of NSAIDs, it is necessary to periodically evaluate a clinical blood test, as well as monitor kidney and liver function, especially in elderly patients (over 65 years of age), and conduct a stool test for occult blood.

Active ingredient

Ketoprofen

Composition

1 ml of the drug contains:

Active ingredient:

Ketoprofen 50 mg

Excipients:

Propylene glycol 400 mg

Ethanol 95% 100 mg (calculated as anhydrous)

Benzyl alcohol 20 mg

Sodium hydroxide solution 10 M to pH 6.0 – 7.5

Water for injections up to 1 ml.

Pregnancy

Inhibition of prostaglandin synthesis may have undesirable effects on pregnancy and/or embryonic development.

Contraindications

Hypersensitivity to ketoprofen or other components of the drug, as well as salicylates or other non-steroidal anti-inflammatory drugs (NSAIDs);

Side Effects

According to the World Health Organization (WHO), undesirable effects are classified according to their frequency of development as follows:

Interaction

Undesirable combinations of drugs The combined use of ketoprofen with other NSAIDs (including selective cyclooxygenase-2 inhibitors), salicylates in high doses is not recommended, due to an increased risk of gastrointestinal bleeding and ulceration of the gastrointestinal mucosa.

Overdose

In case of an overdose of ketoprofen, headache, nausea, vomiting, abdominal pain, vomiting of blood, melena, impaired consciousness, respiratory depression, convulsions, impaired renal function and renal failure may occur.

Recommendations for use

Intravenously, intramuscularly.

Storage conditions

At a temperature not exceeding 25 °C.
Keep out of the reach of children.

Shelf life

3 years

Manufacturer

Grotex LLC, Russia